Seminário: “Inhibition of CK2α using fragment-based drug discovery: From serendipity to specificity”, Prof. Marko Hyvönen – University of Cambridge, UK

Seminário: “Inhibition of CK2α using fragment-based drug discovery: From serendipity to specificity”, Prof. Marko Hyvönen – University of Cambridge, UK